Waiting for Godot: Predictive factors for adjuvant treatment of patients with luminal breast cancer.
Department of Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Serena
S
Di Cosimo
Medical Oncology Unit 1, IRCCS AOU San Martino-IST, Genoa, Italy.
Giacomo
G
Bregni
Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Maria Grazia
MG
Daidone
Laboratory of Methodology for Clinical Research, IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy.
Michela
M
Cinquini
Department of Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Filippo
F
de Braud
Laboratory of Methodology for Clinical Research, IRCCS - Istituto di Ricerche Farmacologiche Mario Negri, Milano, Italy. Electronic address: valter.torri@marionegri.it.
Valter
V
Torri
Adjuvant therapy; Chemotherapy; Luminal breast cancer